MDM2 and osteosarcoma: TBK1 was successfully targeted in oral squamous cell carcinoma and osteosarcoma leading to a decrease in tumor activity43,44 and MDM2 amplifications are known to be involved in tumorigenesis of liposarcoma45–47.